Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

FORTAZ DIN 02212226

Status: Cancelled Post Market
Holder: GLAXOSMITHKLINE INC
Molecule: CEFTAZIDIME (CEFTAZIDIME PENTAHYDRATE)

Health Canada record

Active ingredient(s)CEFTAZIDIME (CEFTAZIDIME PENTAHYDRATE) 2 G
Dosage formPowder For Solution
RouteIntravenous
SchedulePRESCRIPTION
ClassHuman
ATCJ01DD02 CEFTAZIDIME
Original market date28-Dec-2001
Current status date21-Dec-2020
SourceHealth Canada DPD

Establishment licence of the holder

GlaxoSmithKline Inc. — licence 100630, currently licensed, last inspection rating C (2025-09-15).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing CEFTAZIDIME (CEFTAZIDIME PENTAHYDRATE)

DINProductCompanyFormStrengthStatus
02437848CEFTAZIDIME FOR INJECTION BPSTERIMAX INCPowder For SolutionCEFTAZIDIME (CEFTAZIDIME PENTAHYDRATE) 1 GMarketed
02437864CEFTAZIDIME FOR INJECTION BPSTERIMAX INCPowder For SolutionCEFTAZIDIME (CEFTAZIDIME PENTAHYDRATE) 6 GMarketed
02437856CEFTAZIDIME FOR INJECTION BPSTERIMAX INCPowder For SolutionCEFTAZIDIME (CEFTAZIDIME PENTAHYDRATE) 2 GMarketed
02439522CEFTAZIDIME FOR INJECTION, BPSTERIMAX INCPowder For SolutionCEFTAZIDIME (CEFTAZIDIME PENTAHYDRATE) 3 GDormant
02212234FORTAZGLAXOSMITHKLINE INCPowder For SolutionCEFTAZIDIME (CEFTAZIDIME PENTAHYDRATE) 6 GCancelled Post Market
02212218FORTAZGLAXOSMITHKLINE INCPowder For SolutionCEFTAZIDIME (CEFTAZIDIME PENTAHYDRATE) 1 GCancelled Post Market
00640034FORTAZ INJ 1GM/VIALGLAXO CANADA INCPowder For SolutionCEFTAZIDIME (CEFTAZIDIME PENTAHYDRATE) 1 GCancelled Post Market
00640042FORTAZ INJ 2GM/VIALGLAXO CANADA INCPowder For SolutionCEFTAZIDIME (CEFTAZIDIME PENTAHYDRATE) 2 GCancelled Post Market
00640026FORTAZ INJ 500MG/VIALGLAXO CANADA INCPowder For SolutionCEFTAZIDIME (CEFTAZIDIME PENTAHYDRATE) 500 MGCancelled Post Market
00791679FORTAZ PWS INJ 6GM/VIALGLAXO CANADA INCPowder For SolutionCEFTAZIDIME (CEFTAZIDIME PENTAHYDRATE) 6 GCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
3532002-06-17New Drug Submission (NDS)MANUFACTURER NAME CHANGE
47451996-03-07New Drug Submission (NDS)
Request a quote for FORTAZ

How to read a Canadian DIN record